By Lindsay Spratt, Sub Editor
RIO DE JANEIRO - Sanofi Pasteur, a branch of French pharmaceutical giant Sanofi Aventis, is to provide Brazil with eighteen million doses of vaccine to fight the spread of the H1N1 virus, otherwise know as swine flu.
Sanofi Pasteur has signed an agreement with the Brazilian biomedical research unit Butantan Institute, to make and provide the vaccine following an order from the country's Ministry of Health.
An extra fifteen million doses will also be provided if the World Health Organization (WHO) orders vaccine makers to change production from the regular seasonal flu vaccine to the . . .